{"name":"Phathom Pharmaceuticals, Inc.","slug":"phathom-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Vonoprazan ODT-1 or ODT-2 with Water","genericName":"Vonoprazan ODT-1 or ODT-2 with Water","slug":"vonoprazan-odt-1-or-odt-2-with-water","indication":"Other","status":"phase_1"},{"name":"Vonoprazan ODT-1 or ODT-2 without Water","genericName":"Vonoprazan ODT-1 or ODT-2 without Water","slug":"vonoprazan-odt-1-or-odt-2-without-water","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Vonoprazan ODT-1 or ODT-2 with Water","genericName":"Vonoprazan ODT-1 or ODT-2 with Water","slug":"vonoprazan-odt-1-or-odt-2-with-water","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Vonoprazan ODT-1 or ODT-2 without Water","genericName":"Vonoprazan ODT-1 or ODT-2 without Water","slug":"vonoprazan-odt-1-or-odt-2-without-water","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPQ2xXb1YyeWNrVzVsT1BtemxnQmRRMWxZLW1tSHBLTEQtU0FJTUhROGtNUF9XN2pRMHQ3S05tXzZETi1mUENKVWRCZExLZEpxbHhON2phUkVla2Z0VG9zZjBKVm43bU5NNVd4ZVJVZm9oSks0NmlJTFE2LWExa2d5SkNkRnJ5X2sxMkRpbXB2X1gwaUxkdEpiLS0wTnRFRUFycnhwU1I5a3R0aG9sSzBoemc0SThuSVR6dFBfRA?oc=5","date":"2026-02-26","type":"earnings","source":"Stock Titan","summary":"Heartburn drug VOQUEZNA tops 1.1M prescriptions as Phathom targets 2026 profit - Stock Titan","headline":"Heartburn drug VOQUEZNA tops 1.1M prescriptions as Phathom targets 2026 profit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOcjNPZ3V5S2UzRFl2OWxwQkhQX0RtSFhTcGVaUVBVNkJDNklTczBZVjNPTWxBWnpQSlA4SGpsNUtDVXA5Q1BmTHhucmVMUGdPNjZTYnFfRXFLVmlrTjF2V21rTUpMY3liRktFbnJnMkhqNDBObUNiVUhYWHFGSldsUDctUmRMdGZmVW1GUWIxNVBzNTV6MUczdXVlbmhrTWNsUkZfQWc0ZTNFQ3BmSVJWcGxWUU5CRFc1UFozd0Zwbw?oc=5","date":"2026-02-17","type":"pipeline","source":"Stock Titan","summary":"Drugmaker Phathom to break down 2025 results, update in Feb. 26 webcast - Stock Titan","headline":"Drugmaker Phathom to break down 2025 results, update in Feb. 26 webcast","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-06","type":"pipeline","source":"simplywall.st","summary":"Institutional investors in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) see US$88m decrease in market cap last week, although long-term gains have benefitted them. - simplywall.st","headline":"Institutional investors in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) see US$88m decrease in market cap last week, alth","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-08","type":"earnings","source":"simplywall.st","summary":"Revenues Tell The Story For Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) As Its Stock Soars 27% - simplywall.st","headline":"Revenues Tell The Story For Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) As Its Stock Soars 27%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxQM3M2X3pzSmNkNVd0ZTNaV2gyS3pkOXR3NUhXNkxQLWNURUdkcEUwcnBVS0lqTzY1OUtjNWZFbldBT0dISGdHQkZWLU5lN0FFWDF3RUZVbG9ScFFibEJWQXNKeWRoSV9FYThGLWFGUnZaMXN3THZodm44em9TRlNXUmE2SHJFYWhZaUNBQWx5RnBRWkU4NTlRS1ZLdEplY1RZMDhNamdBcmNtZ0NKdzJEOFZneGpmbXN6MTZaT1luRVAxZXRPaDhzZDFGTjdGQ0p4Wi0yZGZyanMzNjY1NExYZXRBODhsSDMtcjFIUmIxdXFLNHEydkpKcERkTFV4TWtmYkZVc2JhVXFxTnh0eUw5eVlB?oc=5","date":"2026-01-07","type":"pipeline","source":"GlobeNewswire","summary":"Phathom Pharmaceuticals Announces Pricing of $130 Million - GlobeNewswire","headline":"Phathom Pharmaceuticals Announces Pricing of $130 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxQSFB0WklhWEJxbE94N2dPanQ5UVVlNTVXaVVNODZrZjR2aE90MWRFanJQaW5lQVhPWW9QWGlmdnBwbmhFRXFjdU10eS1MbEkyUHlKTGFhS1F0b0s1a3FILThRNjBXOGJvR2NabkNXT2JDZk14T1VzN25MUzBveTlaSVY3WE52a0lpRG5WdFpaOFhuWlJEaUZHSmNmYWhtdl9qWkdSeWMtSkxyY0hYSllTNkV4TWZ6QkJncHRSU2U5QndqVFJjdnV0OG1lNGw1aUYzMktYdk9ENWVraWNmV1RfdE1JZ0FiLXFYcWtRTmV3?oc=5","date":"2026-01-07","type":"pipeline","source":"msn.com","summary":"Phathom Pharma plans public offering after reporting preliminary 2025 results - msn.com","headline":"Phathom Pharma plans public offering after reporting preliminary 2025 results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQYmpDZDJncVBibHktM0lHdVREWUhoWTRIV21jX1NnY0xFWGdpd3dkNFFWVVpGNzJWTXJnVzJpd3hoYWRyQmk5NG9mVlRqMHFhSEphWDVKdl9lWk1fVkRXa3FaX2tsX1lqaVJSODFjYjYzeXdUY1ZISkpqSTFDWmlwd1N1bllFYzFnV2Jha085M2k0ZmxvVWRCcVFTdENaWkdZY0JqR0dwRU96Q00?oc=5","date":"2025-11-21","type":"pipeline","source":"Seeking Alpha","summary":"Phathom Pharmaceuticals: Superior Efficacy Drives Vonoprazan Growth (NASDAQ:PHAT) - Seeking Alpha","headline":"Phathom Pharmaceuticals: Superior Efficacy Drives Vonoprazan Growth (NASDAQ:PHAT)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPSzZBZVdDZmVxVGpEZlQyaE5SYU5INURvaGg1Y1RlbE9CamNVUUF5cVdXX194N010M3Q4aV9YODMxMGhrMUtnREMtTFBpVXBVQjhCaDZCWndsYnZrS051NFlrY19qVDFfcXk1WktrOUV3bm5DRGJYMy0yendlcFU1TVIyU3NGemxC?oc=5","date":"2025-10-30","type":"earnings","source":"Yahoo Finance","summary":"Phathom Pharmaceuticals Inc (PHAT) Q3 2025 Earnings Call Highlights: Revenue Surge and ... - Yahoo Finance","headline":"Phathom Pharmaceuticals Inc (PHAT) Q3 2025 Earnings Call Highlights: Revenue Surge and ...","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxQNzhQVExCMHZGd1dkYlNqQ0tHZkRKcFJPTWlFSjAxR3FKbV81bTR1OGR5ZUoxRGN2NXRFbm9lWjdFZnRLcjJrOERtQU1XU3dLbzA4OWFSNkJ5UjdBUTg3LWpLZW9VYmhkX0x4LWpwYVhDYkotRk51UDQ4VjBtRkdyME4yUm5rVUFrYzVxU2tGQTFlc1ZHcTItRkNlb2xrY2wzRGE4Y3EyRnpaWFFUSVU2YjhacVQ2MHZwbl8yT2E2MW9rdklBOEFjNnJBMDBHTXhyMEdHWU5ucnNraENT?oc=5","date":"2025-10-20","type":"earnings","source":"Quiver Quantitative","summary":"Phathom Pharmaceuticals to Hold Conference Call for Q3 2025 Financial Results and Business Update on October 30 - Quiver Quantitative","headline":"Phathom Pharmaceuticals to Hold Conference Call for Q3 2025 Financial Results and Business Update on October 30","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-08","type":"pipeline","source":"simplywall.st","summary":"When Will Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Breakeven? - simplywall.st","headline":"When Will Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Breakeven?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNQmhCZmVydTVlLWZnUGhQSFJCTzZWVm9HalpJeDNoaUdibjV0NG1IalVLTjE0YTJGUTlESWtadzAycUR2TkNvd1hGcWNJenRQdk5ReTdWODQzWnkySjNhcG96NXBWZU9TUzZMbS1TVjFQRDVwUWpSZnQzZ2FyZmR5SzZlNkdteE1fZzRlX1hQTlNlaFJaaDhWUm5iWWNlcmhIby1iNWt3RDYzZm1UVkktazM1VDcyVi1r?oc=5","date":"2025-06-10","type":"regulatory","source":"Seeking Alpha","summary":"Tiny Phathom Pharmaceuticals Just An Got FDA Blessing And Big-Time Upside: Buy (PHAT) - Seeking Alpha","headline":"Tiny Phathom Pharmaceuticals Just An Got FDA Blessing And Big-Time Upside: Buy (PHAT)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygJBVV95cUxOTmpFaU44SXpuQy04Y05jeDNOYW9SdmdySEp5RzZNQ1dUTXoxbFllZm1UQlptNUktNjkwUkRnUm91emVBTVVBMjhHanhjRTZPQWx2ZUpKOEhlQW5oS2tRdl9LdURmRXZhZkF5OUlrUzVnRDVxLWFFUTVCTFdEb0JtY0ZsSVRGc2xZVEVvSkY3NFpLdWdVMlVhYU5ZZ1FkZVlhVnFEQnEtWEtNNVJSUkhod2ZXVnBLZHp4V0tjTkxCalBUcnNWM0o1NjhJckRSdVhKdUpRaV92OUdkSEgyeWFZTndDSUU2TFQtY0dSZWI3ZkJoV1MtSE9tdG1OVzlRa01WRWlEUWVhQjlTaVIwdFdTSTdVSFF2dTIydjlYSGNKTC0yc2ZpZ3dMQXg0bzZpRjlxNDNwMnRLTjE2Y0pXVXZFZDlobnlrMW51RVE?oc=5","date":"2025-06-06","type":"regulatory","source":"GlobeNewswire","summary":"Phathom Pharmaceuticals Announces Positive FDA Decision to - GlobeNewswire","headline":"Phathom Pharmaceuticals Announces Positive FDA Decision to","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}